Antagonistic effects of sulfide and butyrate on proliferation of colonic mucosa
- 129 Downloads
It has been shown that feces of patients with ulcerative colitis uniformly contain sulfate reducing bacteria. Sulfide produced by these bacteria interferes with butyrate-dependent energy metabolism of cultured colonocytes and may be involved in the pathogenesis of ulcerative colitis. Mucosal biopsies from the sigmoid rectum of 10 patients (no caner, polyps, inflammatory bowel disease) were incubated with either NaCl, sodium hydrogen sulfide (1 mmol/L), a combination of both sodium hydrogen sulfide and butyrate (10 mmol/L), or butyrate. Mucosal proliferation was assessed by bromodeoxyuridine labeling of cells in S-phase. Compared to NaCl, sulfide increased the labeling of the entire crypt significantly, by 19% (p < 0.05). This effect was due to an expansion of the proliferative zone to the upper crypt (compartments 3–5), where the increase in proliferation was 54%. Sulfide-induced hyperproliferation was reversed when samples were coincubated with sulfide and butyrate. The study shows that sodium hydrogen sulfide induces mucosal hyperproliferation. Our data support a possible role of sulfide in the pathogenesis of UC and confirm the role of butyrate in the regulation of colonic proliferation and in the treatment of UC.
Key wordsulcerative colitis sulfide sulfate reduction butyrate proliferation
Unable to display preview. Download preview PDF.
- 3.Gibson GR, Macfarlane S, Macfarlane GT: Metabolic interactions involving sulphate reducing and methanogenic bacteria in the large intestine. FEMS Microbiol Ecol 12:117–123, 1993Google Scholar
- 4.Postgate JR: The Sulphate Reducing Bacteria, 2nd ed. Cambridge, UK, Cambridge University Press, 1984Google Scholar
- 5.Florin THJ, Gibson GR, Neale G, Cummings JH: A role of sulfate reducing bacteria in ulcerative colitis. Gastroenterology 98:A170, 1990Google Scholar
- 6.Gibson GR, Cummings JH, Macfarlane GT: Growth and activities of sulphate reducing bacteria in gut contents of healthy subjects and patients with ulcerative colitis. FEMS Microbiol Ecol 86:103–112, 1991Google Scholar
- 8.Gossel TA, Bricker JD: Principles of Clinical Toxicology. New York, Raven, 1990Google Scholar
- 20.Breuer RI, Buto SK, Christ ML, Bean J, Vernia P, Paoluzi P, Di Polo MC, Caprilli R: Rectal irrigation with short chain fatty acids for distal ulcerative colitis. Dig Dis Csi 36:185–192, 1991Google Scholar
- 25.Scheppach W, Bartram P, Richter A, Richter F, Liepold H, Dusel G, Hofstetter G, Ruthlein J, Kasper H: Effect of short-chain fatty acids on the human colonic mucosa in vitro. J Parent Enteral Nutr 16:43–48, 1992Google Scholar
- 26.Moore WEC, Johnsos JL, Holdeman LV: Emendation of Bacteroidaceae and Butyvibrio and descriptions of Desulfomonas gen. nov. and ten new species in the genera Desulfomonas, Butyvibrio, Eubacterium, Clostridum and Ruminococcus. Int J Syst Microbiol 26:238–246, 1976Google Scholar
- 37.Macfarlane GT, Cummings JH: The colonic flora, fermentation, and large bowel digestive function.In The Large Intestine: Physiology, Pathophysiology, and Disease, S Philips, JH Pemberton, RG Shorter (eds). New York, Raven Press, 1991, p 51Google Scholar